(UroToday.com) At the 2020 Society of Urologic Oncology (SUO) virtual annual meeting, Dr. Neal Shore chaired a session examining the use of newer and emerging agents in bladder cancer, which highlighted a presentation by medical oncologist Dr. Arjun Balar discussing the emerging utility of immune checkpoint inhibitors in muscle-invasive bladder cancer (MIBC).